These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 11488521)
21. The potent microtubule-stabilizing agent (+)-discodermolide induces apoptosis in human breast carcinoma cells--preliminary comparisons to paclitaxel. Balachandran R; ter Haar E; Welsh MJ; Grant SG; Day BW Anticancer Drugs; 1998 Jan; 9(1):67-76. PubMed ID: 9491794 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide. Gertsch J; Meier S; Müller M; Altmann KH Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273 [TBL] [Abstract][Full Text] [Related]
23. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide. Mínguez JM; Kim SY; Giuliano KA; Balachandran R; Madiraju C; Day BW; Curran DP Bioorg Med Chem; 2003 Jul; 11(15):3335-57. PubMed ID: 12837544 [TBL] [Abstract][Full Text] [Related]
25. Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy. Giannakakou P; Fojo T Clin Cancer Res; 2000 May; 6(5):1613-5. PubMed ID: 10815877 [No Abstract] [Full Text] [Related]
26. Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent. Chao SK; Lin J; Brouwer-Visser J; Smith AB; Horwitz SB; McDaid HM Proc Natl Acad Sci U S A; 2011 Jan; 108(1):391-6. PubMed ID: 21173253 [TBL] [Abstract][Full Text] [Related]
27. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells. Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345 [TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity. Smith AB; Sugasawa K; Atasoylu O; Yang CP; Horwitz SB J Med Chem; 2011 Sep; 54(18):6319-27. PubMed ID: 21870795 [TBL] [Abstract][Full Text] [Related]
29. Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence. Guo B; Rodriguez-Gabin A; Prota AE; Mühlethaler T; Zhang N; Ye K; Steinmetz MO; Horwitz SB; Smith AB; McDaid HM Mol Pharmacol; 2020 Aug; 98(2):156-167. PubMed ID: 32591477 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines. McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947 [TBL] [Abstract][Full Text] [Related]
31. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel. Dabydeen DA; Florence GJ; Paterson I; Hamel E Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743 [TBL] [Abstract][Full Text] [Related]
32. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide. Harried SS; Lee CP; Yang G; Lee TI; Myles DC J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029 [TBL] [Abstract][Full Text] [Related]
33. Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol. Paterson I; Naylor GJ; Gardner NM; Guzmán E; Wright AE Chem Asian J; 2011 Feb; 6(2):459-73. PubMed ID: 21254424 [TBL] [Abstract][Full Text] [Related]
34. Validation and evaluation of an HPLC methodology for the quantification of the potent antimitotic compound (+)-discodermolide in the Caribbean marine sponge Discodermia dissoluta. Valderrama K; Castellanos L; Zea S J Sep Sci; 2010 Aug; 33(15):2316-21. PubMed ID: 20603836 [TBL] [Abstract][Full Text] [Related]
35. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. Shahabi S; Yang CP; Goldberg GL; Horwitz SB Gynecol Oncol; 2010 Nov; 119(2):345-50. PubMed ID: 20674962 [TBL] [Abstract][Full Text] [Related]
36. Mariculture and natural production of the antitumoural (+)-discodermolide by the Caribbean marine sponge Discodermia dissoluta. Ruiz C; Valderrama K; Zea S; Castellanos L Mar Biotechnol (NY); 2013 Oct; 15(5):571-83. PubMed ID: 23728846 [TBL] [Abstract][Full Text] [Related]
37. Discodermolide analogues as the chemical component of combination bacteriolytic therapy. Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874 [TBL] [Abstract][Full Text] [Related]
38. Structural Basis of Microtubule Stabilization by Discodermolide. Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984 [TBL] [Abstract][Full Text] [Related]